Initial 3-Weeks’ Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial Fang YangHui LeiGang Zhao Original Research Article Open access 09 September 2014 Pages: 755 - 761
Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects Anders GummessonHaiyan LiBoaz Hirshberg Original Research Article 11 September 2014 Pages: 763 - 772
Anti-Oxidative Stress Effect of Loading-Dose Rosuvastatin Prior to Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Prospective Randomized Controlled Clinical Trial Dong LiangQian ZhangFeng Cao Original Research Article 04 September 2014 Pages: 773 - 781
Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China Xiaohua HouShengliang ChenGwendolyn Janssen-van Solingen Original Research Article Open access 26 September 2014 Pages: 783 - 793
Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers Akwete AdjeiRobert J. KupperLaurence Greenhill Original Research Article 02 October 2014 Pages: 795 - 805
A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial Daniela BaldoniShirin BrudererJasper Dingemanse Original Research Article 21 October 2014 Pages: 807 - 818
Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment Junichi YamamotoNathalie ToublancArmel Stockis Original Research Article 14 October 2014 Pages: 819 - 828